Osral 60mg Tablet is a medicine used in the treatment and prevention of osteoporosis in postmenopausal women. It helps in preventing bone loss that can develop in women after menopause. It makes the bone stronger and lowers the risk of fractures.

It is Selective estrogen receptor modulators (SERM) used in osteoprosis

Uses of Osral Tablet

Treatment and prevention of Post menopausal osteoporosis

Benefits of Osral Tablet

In Treatment and prevention of Post menopausal osteoporosis

Osteoporosis is a common condition that weakens bones, making them fragile and more likely to break. It often occurs in women after menopause (end of a woman's menstrual cycles) and is known as post-menopausal osteoporosis. Osral 60mg Tablet helps to keep your bones strong and healthy and reduces the risk of osteoporosis. It also helps maintain bone density and reduces your risk of bone fracture. You should use this medicine as it is prescribed, and for as long as it is prescribed by your doctor.

Side effects of Osral Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Osral

Leg cramps
Peripheral edema
Flu-like symptoms
Joint pain
Sweating
Hot flashes

How to use Osral Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Osral 60mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol

CAUTION

Caution is advised when consuming alcohol with Osral 60mg Tablet. Please consult your doctor.

Pregnancy

UNSAFE

Osral 60mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding

UNSAFE

Osral 60mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

SAFE

Osral 60mg Tablet does not usually affect your ability to drive.

Kidney

CAUTION

Osral 60mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Osral 60mg Tablet may be needed. Please consult your doctor.
Use of Osral 60mg Tablet is not recommended in patients with severe kidney disease.

Liver

UNSAFE

Osral 60mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Osral 60mg Tablet

₹6.9/Tablet

Ralista Tablet

Cipla Ltd

₹12.2/tablet

77% costlier

Bonebay 60mg Tablet

Novartis India Ltd

₹9.55/tablet

38% costlier

Ronal 60mg Tablet

Blue Cross Laboratories Ltd

₹6.88/tablet

same price

Femoral 60mg Tablet

Duckbill Drugs Pvt Ltd

₹10.14/tablet

47% costlier

Ralosto 60mg Tablet

Abbott L

₹9.99/tablet

45% costlier

View all substitutes

Quick tips

You have been prescribed Osral 60mg Tablet for the treatment of and prevention of postmenopausal osteoporosis.
Consult your doctor immediately if you notice lumps in your breast, sudden weakness, chest pain, vision problems, and pain, swelling, warmth, or redness in one or both legs.
Inform your doctor if you are on estrogen therapy.
Inform your doctor immediately if you observe bleeding/spotting from the vagina during the treatment.
Try to increase body movements and do not restrict yourself at one place or position for a long time while taking Osral 60mg Tablet.
Remember to do light exercises such as brisk walking to keep yourself active.
Try to include calcium and vitamin D-rich food in your diet like dairy products, green leafy vegetables, egg yolk or simply get it naturally from sunlight.
Osteoporosis makes your bones weaker, they may break more easily if you fall. You can try to reduce the risk of falls by wearing well-fitting shoes or slippers and checking your home for hazards such as uneven rugs, trailing wires, and slippery floors.

Fact Box

Chemical Class

Aryl-Phenylketone Derivative

Habit Forming

Therapeutic Class

GYNAECOLOGICAL

Action Class

Selective estrogen receptor modulators (SERM)- Osteoporosis

Patient concerns

I had hot flash, sweating and ganrahat

Dr. Pushkar Mani

Physician

Seems like post menopausal syndrome. Visit a gynaecologist.

Ovaries taken out chest pain and intense sweat high heart beats

Dr. Suman Rao

Obstetrics and Gynaecology

These are the symptoms of menopause. Consult a gynaec nearby and discuss about post menopausal therapy

Having urine burning problem past month. with the homeop medicine 70% relief i got. now i stopped medicine to have. five year back hystectomy done overies still remain. due to computer work eyes get dried and tired. shoulders also pain. past 1.7 year back pain started. some time hot flashes also come suddenly. all blood investigation and u/s are normal. as per dr. advise take sweet less. hair fall are more. no dandruff.

Dr. Megha Gupta

Obstetrics and Gynaecology

It is normal to have hot flashes and these post menopausal symptoms after hysterectomyYou can take hormone therapy if you want however symptoms will recurrent when you stop treatment

Related lab tests

Calcium

Top Gynecologists

4.6 ★

4.4 ★

4.3 ★

4.4 ★

4.6 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Bikle DD. Agents That Affects Bone Mineral Homoestasis. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 766.
Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1177-80.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1191-92.
Drugs.com. Raloxifene. [Accessed 02 Apr. 2019] (online) Available from:
Raloxifene. Indianapolis, Indiana: Eli Lilly and Company; 1997 [revised Jul. 2007]. [Accessed 02 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from:

Marketer details

Name: Panacea Biotec Ltd

Address: Ambala- Chandigarh Highway, Lalru – 140501, Punjab

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.